Skip to main content
. 2022 Mar 3;9:727103. doi: 10.3389/fmed.2022.727103

Table 1.

Patient characteristics by overall mortality (N = 4,610).

All
(N = 4,610)
Non-survivor
(N = 2,511)
Survivor
(N = 2,099)
p-value
Basic characteristics
Age, years 66.4 ± 16.4 69.7 ± 15.5 62.5 ± 16.5 <0.01
Follow-up duration, years 1.2 ± 1.3 0.4 ± 0.7 2.1 ± 1.3 <0.01
Male 2,943 (63.8%) 1,658 (66.0%) 1,285 (61.2%) <0.01
BMI 24.4 ± 4.7 24.0 ± 4.7 24.9 ± 4.7 <0.01
Charlson comorbidity index 2.4 ± 1.6 2.7 ± 1.6 1.9 ± 1.5 <0.01
Active cancer 627 (13.6%) 523 (20.8%) 104 (5.0%) <0.01
Severity and managements
APACHE II score 25.1 ± 7.5 27.8 ± 7.1 21.9 ± 6.7 <0.01
Shock 2,134 (46.3%) 1,500 (59.7%) 634 (30.2%) <0.01
Ventilator 3,391 (73.6%) 2,074 (82.6%) 1,317 (62.7%) <0.01
Renal replacement therapy (RRT)
RRT initiated during ICU admission 738 (16%) 546 (21.7%) 192 (9.2%) <0.01
RRT for end-stage renal disease 130 (2.8%) 69 (2.8%) 61 (2.9%) 0.75
Reasons for ICU admission
Acute cardiac disorder 221 (4.8%) 42 (2.6%) 156 (7.4%) <0.01
Acute gastrointestinal disorder 287 (6.2%) 146 (5.8%) 141 (6.7%) 0.22
Acute neurological disorder 444 (9.6%) 171 (6.8%) 273 (13.0%) <0.01
Acute renal disorder 124 (2.7%) 57 (2.3%) 67 (3.2%) 0.06
Respiratory disorder 420 (9.1%) 289 (11.5%) 131 (6.2%) <0.01
Sepsis 2,235 (48.5%) 1,402 (55.8%) 833 (39.7%) <0.01
Others 879 (19.1%) 381 (15.2%) 498 (23.7%) <0.01
Outcomes
ICU-stay, days 9.9 ± 8.4 11.3 ± 8.8 8.3 ± 7.6 <0.01
Hospital-stay, days 24.2 ± 19.0 26.3 ± 19.7 21.8 ± 17.9 <0.01
Ventilator-day, days 9.7 ± 9.1 10.8 ± 9.6 8.1 ± 8.0 <0.01
In-hospital mortality 1,291 (28%) 1,291 (28%) NA
90-day mortality 1,741 (37.8%) 1,741 (37.8%) NA
1-year mortality 2,151 (46.7%) 2,151 (46.7%) NA

BMI, body mass index; APACHE II, acute physiology and chronic health evaluation; RRT, renal replacement therapy; ICU, intensive care unit; NA, not applicable.